BioElectronics BIEL Conference Call 7/28/09 - July 28, 2009

BioElectronics Corporation (BIEL.PK) stock is surging today as the company plans to hold a conference call on July 28, 2009 on FDA filings. Shares of BIEL are up 28% to $0.055. Expect shares to catch a bid leading up the the Conference Call as traders and investors are likely buying the rumor and will sell the news. Discuss BIEL.PK

BioElectronics to Hold Conference Call to Discuss Clinical Data Results and Status of FDA Filings

Dr. David G. Genecov to Present Results of a Clinical Study and Management Team to Provide Update on Corporate Activities, Other Clinical Studies, Distribution and FDA Filings

FREDERICK, MD--(Marketwire - 07/22/09) - BioElectronics Corp. (Pinksheets:BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced a conference call will be held at 11AM (EDT), Tuesday, July 28th to discuss the results of a clinical study recently completed under the direction of David G. Genecov, M.D. FACS FAAP and Joel Brook, DPM, MS, FACFAS. The management team will also provide its stakeholders with an update on corporate activities and information on the status of FDA filings.

Full Article

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free